Advertisement

Topics

Companies Related to "Rift Valley fever virus infection mechanism identified" [Most Relevant Company Matches] RSS

16:00 EDT 16th August 2018 | BioPortfolio

Here are the most relevant search results for "Rift Valley fever virus infection mechanism identified" found in our extensive corporate database of over 50,000 company records.

Showing "Rift Valley fever virus infection mechanism identified" Companies 1–25 of 973

Relevant

Ichor Medical Systems, Inc.

Ichor Medical Systems’ TriGrid™ Delivery System (TriGrid) is the first integrated and fully automated device for electroporation-mediated DNA administration in humans. Ichor, a privately held biotech company based in San Diego, CA, is collaborating with partners to provide its enabling TriGrid platform as a means for delivery of DNA drugs and vaccines i...


NanoViricides, Inc.

NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide™ class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral dis...

Sirion Therapeutics, Inc.

Herpetic Keratitis is the number one infectious cause of corneal blindness in the U.S. Herpes simplex virus infections are very common, with nearly 60% of the US population showing evidence of infection by age five. Approximately 1% of infected patients develop ocular outbreaks, with 20,000 primary cases of ocular herpes diagnosed in the US each year. After the primary infection, ocular HSV typic...


Novirio Pharmaceutical Incorporated

Novirio Pharmaceuticals is an independent biopharmaceutical company engaged in the discovery and development of pharmaceuticals for the treatment of life threatening human viral diseases. Building on our expertise in nucleoside chemistry and biology and other small molecule therapeutic compounds, we are positioned to become a leader in the antiviral pharmaceuticals market. Our efforts focus on sig...

FluGen, Inc.

FluGen, Inc. is a privately held biotechnology company founded in 2005 and based in Madison, WI. The company has been developing novel influenza vaccine technology first invented at the University of Wisconsin-Madison, in the laboratories of Dr. Yoshihiro Kawaoka and Dr. Gabriele Neumann, and exclusively licensed to FluGen by WARF. The REDEE FLU influenza ...

Gilead Sciences

Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions forpatients and the people who care for them. The Company discovers, develops and commercializes proprietary therapeutics for important viral diseases, including the currently marketed product VISTIDE-Registered Trademark- (cidofovir injection) for the treatment of cytomegalovirus ("CMV") ...

ZymoGenetics, Inc.

ZymoGenetics is a biopharmaceutical company focused on the development and commercialization of therapeutic proteins for the treatment of human diseases. The company has developed and is marketing RECOTHROM® Thrombin, topical (Recombinant) in the United States. ZymoGenetics has two product candidates in Phase 2 clinical development: PEG-Interferon lambd...

Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. (NASDAQ-PPHM) is a clinical stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection. The Company is advancing three separate clinical programs with its lead product candidates bavituximab and Cotara®. Bavituximab and Cotara are both in Phase II clinical studies for the treatment o...

DPR Construction

DPR Construction is a forward-thinking national general contractor and construction manager specializing in technically complex and sustainable projects for the advanced technology/mission critical, life sciences, healthcare, higher education and corporate office markets. Founded in 1990, DPR is a privately held, employee-owned company that has grown to...

Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism pr...

Inviragen, Inc.

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's lead product candidate is a vaccine to protect against dengue fever. Inviragen is also developing vaccines to protect against hand, foot and mouth disease and Japanese encephalitis, both of which affect millions of children in Asia. Vaccines in preclin...

Viroblock SA

Viroblock is dedicated to developing and commercializing a new generation of anti-viral products with a novel mechanism of action against enveloped viruses. Enveloped viruses represent more than 60% of all existing viruses and include major human pathogens such as human and avian influenzas, the hepatitis B and C viruses and the AIDS virus.

Biota Holdings Limited

Biota is a leading anti-infective drug development company based in Melbourne Australia, with key expertise in respiratory diseases, particularly influenza. Biota developed the first-in-class neuraminidase inhibitor, zanamivir, subsequently marketed by GlaxoSmithKline as Relenza. Biota research breakthroughs have included novel nucleoside analogues designe...

Valley Preferred

Valley Preferred is Pennsylvania's leading provider-owned, preferred provider organization. In partnership with 3,800 community-based doctors and 18 hospitals, Valley Preferred connects local businesses and individuals with contracted health insurance companies. Valley Preferred's corporate philosophy is reflected in its brand performance promise of "Care Beyond the Coverage." Through BeneFIT, its...

Valley Presbyterian Hospital

Founded in 1958, Valley Presbyterian Hospital, a non-profit and nonsectarian hospital, has remained focused on meeting the medical needs of the community for over 50 years. While VPH has grown to become one of the largest acute care hospitals in the San Fernando Valley, it continues to provide patient-centered care for a healthier community. The 350-bed fa...

Inviragen, Inc. and Duke-NUS

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's lead product candidate is a vaccine to protect against dengue fever. Inviragen is also developing vaccines to protect against hand, foot and mouth disease, chikungunya and Japanese encephalitis which affect millions of individuals in Asia. Vaccines in ...

Inviragen, Inc. and PharmaJet, Inc.

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's lead product candidate is a vaccine to protect against dengue fever. Inviragen is also developing vaccines to protect against hand, foot and mouth disease and Japanese encephalitis, both of which affect millions of children in Asia. Vaccines in preclin...

Nature Valley

Nature Valley created the granola bar category in 1975 and brings great taste to active consumers looking for wholesome snacks. Nature Valley offers eight great-tasting granola snacks: Crunch Granola Bars, Sweet & Salty Nut Granola Bars, Chewy Trail Mix Bars, Granola Thins, Yogurt Granola Bars, Roasted Nut Crunch Bars, Granola Nut Clusters and Protein Bars...

Telephus Medical LLC

Telephus Medical, located in San Diego, California, is developing a suite of monoclonal antibody products designed to neutralize key staphylococcal enzymes used to attach to host tissues, replicate and evade immune attack. These enzymes, are central components of the bacterial machinery staphylococci utilize to invade host tissues, evade the immune respons...

InBios International, Inc.

InBios International, Inc. is a medical diagnostic company that specializes in developing, manufacturing and marketing medical diagnostic tests for the detection of infectious diseases. Since its inception in 1996, InBios has developed proprietary technologies useful in the development of rapid and ELISA based immunodiagnostic assays. It has also licensed antigens from major corporations and resea...

Valley Medical Center Foundation

The Valley Medical Center Foundation is an independent, community-driven 501c3 nonprofit organization founded to support Silicon Valley’s most vital public health institution – Santa Clara Valley Medical Center Hospitals & Clinics. In partnership with SCVMC, the VMC Foundation raises philanthropic dollars to improve existing services, pioneer new ...

Profectus BioSciences, Inc.

Profectus BioSciences, Inc. is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases with a goal of reducing morbidity and mortality. Since its inception in 2003, the Company’s strategic intent has been to develop and acquire the technologies needed to deliver on that mission within high value mark...

AGY Therapeutics Incorporated

AGY is an emerging biopharmaceutical company, discovering and developing novel treatments for diseases of the nervous system. AGY scientists have established and utilized a unique mechanism-based approach to identify and characterize new molecules for disease intervention. The intricate molecular networks activated by stress, injury, infection, degeneration and toxins offer a unique basis for sele...

Virapur, LLC

Virapur is a virus production and purification company. Our expert virologists have years of experience in producing and purifying adenovirus, AAV, lentivirus, retroviruses and many other human and animal viruses. We provide ready to go kits as well as custom virus services to meet your research needs.

Bio-Bridge Science

Bio-Bridge Science, Inc., a development stage biotechnology company, engages in the commercial development of vaccines for the prevention and treatment of human infectious diseases. The company is currently developing and commercializing HIV-PV Vaccine I to prevent and treat infection by the human immunodeficiency virus (HIV). It develops HIV vaccines for both preventive and therapeutic purposes. ...


More From BioPortfolio on "Rift Valley fever virus infection mechanism identified"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks